Markman Biologics was founded to create a value ad in the healing of acute and chronic wounds. Markman Biologics intellectual property pertains to resurfacing of currently utilized smooth surface reconstructive grafts, including but not limited to, acellular dermal, split thickness skin, and decellularize amnion/chorion tissue. By micro surfacing tissue grafts, it increases the surface area, graft - host cellular interaction, adhesion of the graft, and reduces the time of healing.